BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 22538855)

  • 1. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
    Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
    Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
    Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
    J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
    Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
    Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the Peritransplantation Period.
    Inoue T; Ikegame K; Kaida K; Okada M; Yoshihara S; Tamaki H; Fujimori Y; Soma T; Ogawa H
    J Immunol; 2016 Jan; 196(1):469-83. PubMed ID: 26621858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cells induced the enrichment of CD4
    Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L
    Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation.
    van der Merwe M; Abdelsamed HA; Seth A; Ong T; Vogel P; Pillai AB
    J Immunol; 2013 Dec; 191(11):5764-76. PubMed ID: 24190658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.
    Beres AJ; Haribhai D; Chadwick AC; Gonyo PJ; Williams CB; Drobyski WR
    J Immunol; 2012 Jul; 189(1):464-74. PubMed ID: 22649199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.
    Pothoven KL; Kheradmand T; Yang Q; Houlihan JL; Zhang H; Degutes M; Miller SD; Luo X
    Am J Transplant; 2010 Aug; 10(8):1774-84. PubMed ID: 20626386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
    Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
    J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of FoxP3+CD4+25+ regulatory T cells following hemopoietic stem cell transplantation: role of bone marrow-derived facilitating cells.
    Taylor KN; Shinde-Patil VR; Cohick E; Colson YL
    J Immunol; 2007 Aug; 179(4):2153-62. PubMed ID: 17675474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
    Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
    Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.
    Sun JB; Raghavan S; Sjöling A; Lundin S; Holmgren J
    J Immunol; 2006 Dec; 177(11):7634-44. PubMed ID: 17114433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
    Poggi A; Zocchi MR
    Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells.
    Shin HJ; Baker J; Leveson-Gower DB; Smith AT; Sega EI; Negrin RS
    Blood; 2011 Aug; 118(8):2342-50. PubMed ID: 21734238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Foxp3
    Chen YB; Efebera YA; Johnston L; Ball ED; Avigan D; Lekakis LJ; Bachier CR; Martin P; Duramad O; Ishii Y; Han S; Jung YJ; Lee D; Kunkel L; Negrin RS; Bui JD
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):625-634. PubMed ID: 28104514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of graft-versus-host disease: role of regulatory T lymphocytes.
    Hess AD
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):13-21. PubMed ID: 16399597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.